SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Hassett J, Parker J. Laboratory practices in reporting flow cytometry phenotyping results for leukemia/lymphoma specimens: Results of a survey. Cytometry 1995; 22: 264281.
  • 2
    Brando B, Sommaruga E. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy. Cytometry 1993; 14: 294306.
  • 3
    MartiniED, HautcourtJL, BrandoB, LawryJ, O'ConnorJE, SansonettyF, editors. First European Quality Control of Cellular Phenotyping by Flow Cytometry. Paris: Frison-Roche; 1990.
  • 4
    Maecker TH, Frey T, Nomura LE, Trotter J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry Part A 2004; 62A: 169173.
  • 5
    Young IT. Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 1977; 25: 935941.
  • 6
    Stelzer GT, Marti G, Hurley A, McCoy P, Lovett EJ, Schwartz A. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization and validation of laboratory procedures. Cytometry 1997; 30: 214230.
  • 7
    Borowitz MJ, Bray R, Gascoyne R, Melnick S, Parker JW, Picker L, Stetler-Stevenson M. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation. Cytometry 1997; 30: 236244.
  • 8
    Sutherland DR, Keeney M, Gratama JW. Enumeration of CD34+ hematopoietic stem and progenitor cells. In: RobinsonJR, DarzynkiewiczZ, DeanPN, RabinovitchPS, StewartCS, TankeHJ, WheelessLL, editors. Current Protocols in Cytometry. New York: Wiley; 2003. Unit 6.4, pp 123.
  • 9
    Gratama JW, Kraan J, Keeney M, Mandy F, Sutherland DR, Wood BL. Enumeration of Immunologically Defined Cell Populations by Flow Cytometry: Approved Guideline, 2nd ed (H42-A2, Vol. 27, No. 16). Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
  • 10
    Monici M. Cell and tissue autofluorescence research and diagnostic applications. Biotechnol Annu Rev 2005; 11: 227256.
  • 11
    Perfetto SP, Roederer M. Increased immunfluorescence sensitivity using 532 nm laser excitation. Cytometry Part A 2007; 71A: 7379.
  • 12
    Mayeno AN, Hamann KJ, Gleich J. Granule-associated flavin adenine dinucleotide (FAD) is responsible for eosinophil autofluorescence. J Leukoc Biol 1992; 51: 172175.
  • 13
    Hulspas R, Bauman JGJ. The use of fluorescent in situ hybridization for the analysis of nuclear architecture by confocal microscopy. Cell Biol Int Rep 1992; 16: 739747.
  • 14
    Mosiman VL, Patterson BK, Canterero L, Goolsby CL. Reducing autofluorescence in flow cytometry: An in situ method. Cytometry 1997; 30: 151156.
  • 15
    Hodge SJ, Hodge GL, Holmes M, Reynolds PN. Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease. Cytometry Part B 2004; 61B: 2734.
  • 16
    Hed J, Hallden G, Johansson SG, Larsson P. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods 1987; 101: 119125.
  • 17
    Steinkamp JA, Stewart CS. Dual-laser, differential fluorescence correction method for reducing cellular background autofluorescence. Cytometry 1986; 7: 566574.
  • 18
    Alberti S, Parks DR, Herzenberg LA. A single laser method for subtraction of cell autofluorescence in flow cytometry. Cytometry 1987; 8: 114119.
  • 19
    Roederer M, Murphy RF. Cell-by-cell autofluorescence correction for low signal-to-noise systems: Application to epidermal growth factor endocytosis by 3T3 fibroblasts. Cytometry 1986; 7: 558565.
  • 20
    Roederer M. Spectral compensation for flow cytometry: Visualization, artifacts, limitations, and caveats. Cytometry 2001; 45: 194205.
  • 21
    McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, Nixon DF, Ottinger J, Oxford C, Evans TG, Asmuth DM. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach. Cytometry Part A 2008; 73A: 400410.
  • 22
    Baumgarth N, Bigos M. Optimization of emission optics. In: DarzynkiewiczZ, RoedererM, TankeHJ, editors.Methods in Cell Biology, Vol. 75: Cytometry: New Developments, 4th ed. San Diego, CA: Academic Press; 2004. pp 322.
  • 23
    Decker JM. Introduction to immunology. In: DeckerJM, editor. The 11th Hour Series, 3rd ed. Wiley-Blackwell; 2000. p 6.
  • 24
    Gebhardt BM. Evidence for cross-reactivity between herpesvirus and the acetylcholone receptor. J Neuroimmunol 2000; 105: 145153.
  • 25
    Oliveira MF, Bijovsky AT, Carvalho TU, de Souza W, Alves MJ, Colli W. A monoclonal antibody to Trypanosoma cruzi trpomastigotes recognizes a myosin tail epitope. Parasitol Res 2001; 87: 10431049.
  • 26
    Kim MJ, Kim MK, Kang JS. An epitope shared by cellular cytokeratin and Orientia tsutsugamushi. Microb Pathog 2006; 41: 125132.
  • 27
    Capel PJ, van de Winkel JG, van den Herik-Oudijk IE, Verbeek JS. Heterogeneity of human IgG Fc receptors. Immunomethods 1994; 4: 2534.
  • 28
    Gratama JW, Van der Linden R, Van der Holt B, Bolthuis RLH, Van de Winkel JGJ. Analysis of factors contributing to the formation of monoclonal cell aggregates (‘escapees’) in flow cytometric immunophenotyping. Cytometry 1997; 29: 250260.
  • 29
    Srivastava P, Sladek TL, Goodman MN, Jacobberger JW. Streptavidin-based quantitative staining of intracellular antigens for flow cytometric analysis. Cytometry 1992; 13: 711721.
  • 30
    Kantor AB, Roederer M. FACS analysis of leukocytes. In: HerzenbergLA, WeirDM, Herzenberg, LA, BlackwellC, editors. Handbook of Experimental Immunology, 5th ed. Cambridge, MA: Blackwell Scientific; 1996. Chapter 49.
  • 31
    Van Vugt MJ, van den Herik-Oudijk IE, van de Winkel JGJ. Binding of PE-Cy5 conjugates to the human high-affinity receptor for IgG (CD64). Blood 1996; 88: 23582361.
  • 32
    Roederer M, Kantor AB, Parks DR, Herzenberg LA. Cy7PE and Cy7APC: Bright new probes for immunofluorescence. Cytometry 1996; 24: 191197.
  • 33
    Lanza F, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen: An update. J Biol Regul Homeost Agents 2001; 15: 113.
  • 34
    Sutherland DR, Kuek N, Anderson T, Acton E, Barth D, Keeney M. Use of FLAER-based white blood cell assay in the primary screening of PNH clones. Am J Clin Pathol (in press).
  • 35
    Stewart C, Stewart S. Cell preparation for the identification of leukocytes. In: DarzynkiewiczZ, RobinsonJ, CrissmanH, editors. Methods in Cell Biology. New York: Academic Press; 1994. pp 3960.
  • 36
    Lowdell MW. Data analysis in flow cytometry. In: McCarthyDA, MaceyMG, editors. Cytometric Analysis of Cell Phenotype and Function. Cambridge, UK: Cambridge Press; 2001. pp 8999.
  • 37
    O'Gorman MRG, McNally A, Anderson D, Myones B. A rapid whole blood lysis technique for the diagnosis of moderate or severe leukocyte adhesion deficiency (LAD). Ann NY Acad Sci 1993; 667: 427430.
  • 38
    Keeney M, Gratama JW, Chin-Yee IH, Sutherland DR. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry—Time to let go! Cytometry 1998; 34: 280283.
  • 39
    O'Gorman MRG, Thomas J. Isotype controls—Time to let go? Cytometry 1999; 38: 7880.
  • 40
    Donnenberg AD, Donnenberg V. Understanding clinical flow cytometry. In: O'GormanMRG, DonnenbergAD, editors. Handbook of Human Immunology, 2nd ed. Boca Raton, FL: CRC Press; 2008. pp 181220.
  • 41
    Langweiler M, Givan AL. Flow cytometry and quality control: An uneasy alliance. In: StewartC, NicholsonJ, editors. Immunophenotyping. New York: Wiley-Liss; 2000. pp 2349.
  • 42
    Kreissig C, Kirsch A, Serke S. Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 1994; 3: 263289.
  • 43
    Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE Guidelines. Cytometry (Commun Clin Cytometry) 1998; 34: 6170.
  • 44
    Baumgarth N, Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 2000; 243: 7797.
  • 45
    Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: Unraveling the immune system. Nature Rev 2004; 4: 648655.
  • 46
    Agrawal YP, Mahlamäki EK, Penttilä IM. Use of quality control standards in clinical flow cytometry. Ann Med 1991; 23: 127133.
  • 47
    Owens MA, Vall HG, Hurley AA, Wormsley SB. Validation and quality control of immunophenotyping in clinical flow cytometry. J Immunol Methods 2000; 243: 3355.
  • 48
    Perfetto SP, Ambrozak D, Nguyen R, Chattopadhyay P, Roederer M. Quality assurance for polychromatic flow cytometry. Nat Protoc 2006; 1: 15221530.
  • 49
    Sebestyén Z, Nagy P, Horváth G, Vámosi G, Debets R, Gratama JW, Alexander DR, Szöllősi J. Long wavelength fluorophores and cell-by-cell correction for autofluorescence significantly improves the accuracy of flow cytometric energy transfer measurements on a dual-laser benchtop flow cytometer. Cytometry 2002; 48: 124135.
  • 50
    MasonD, AndréP, BensussanA, BuckleyC, CivinC, ClarkE, de HaasM, GoyertS, HadamM, HartD, HořejšiV, JonesY, MeuerS, MorrisseyJA, Schwartz-AlbiezR, ShawS, SimmonsD, TurniL, UguccioniM, van der SchootE, VivierE, ZolaH, editors. Leucocyte Typing VII. New York: Oxford University; 2002.
  • 51
    Couchman JR. Commercial antibodies: The good, bad and really ugly. J Histochem Cytochem 2009; 57: 78.
  • 52
    Schultz C, Rott C, Temming P, von Puttkammer J, Bucsky P. Influence of specimen age and use of different negative controls in determination of intracytoplasmic levels of cytokines after whole-blood culture assay. Clin Diagn Lab Immunol 2002; 9: 295298.
  • 53
    Saper CB. A guide to the perplexed on the specificity of antibodies. J Histochem Cytochem 2009; 57: 15.
  • 54
    Landay AL, Muirhead KA. Procedural guidelines for performing immunophenotyping by flow cytometry. Clin Immunol Immunopathol 1989; 52: 4860.
  • 55
    McCoy JP, Carey JL, Krause JR. Quality control in flow cytometry for diagnostic pathology. I. Cell surface phenotyping and general laboratory procedures. Am J Clin Pathol 1990; 93: S27S37.
  • 56
    Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay. Clin Lab Med 2007; 27: 469485.
  • 57
    Gratama JW, Sutherland DR, Keeney M, Papa S. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. J Biol Regul Homeost Agents 2001; 15: 1422.
  • 58
    Le NT, Chao N. Regulating regulatory T cells. Bone Marrow Transplant 2007; 39: 19.